Panelists discuss how aflibercept 8 mg maintains a safety profile similar to 2 mg and how workflow, systemic risk, and ...

Panelists discuss how clinicians manage suboptimal responders by focusing on stability rather than complete dryness, using ...

Credit: Getty Images. The BLA is supported by data from the pivotal PULSAR and PHOTON trials. The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application ...

Patients with diabetic macular edema can expect similar BCVA improvements and CST reductions using an aflibercept biosimilar compared with conventional aflibercept. An aflibercept biosimilar is ...

P041, an aflibercept biosimilar, showed noninferiority to originator aflibercept (Eylea) in maintaining vision in nAMD patients over 52 weeks. The study involved 168 patients, with 145 completing the ...

Intraretinal hyperreflective foci, intraretinal hard exudates, and epiretinal membrane formation were lower after treatment with faricimab (Vabysmo) compared with aflibercept (Eylea) for patients with ...

Please provide your email address to receive an email when new articles are posted on . Eyes with neovascular age-related macular degeneration treated with aflibercept were almost three times more ...

Please provide your email address to receive an email when new articles are posted on . Patients with wet age-related macular degeneration who were treated with high-dose aflibercept experienced ...

The FDA approved a higher dosage of aflibercept (Eylea) for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy. The FDA approved Eylea HD (aflibercept), a ...

Find out how higher dose aflibercept may reduce injection burden while preserving vision in retinal vasculopathy.

An FDA target action date of August 19, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application ...

Pune, India - (NewMediaWire) - March 7, 2023 - "Aflibercept" Size, Scope, and Forecast 2023-2031 report has been added to the Market Research Archive of Absolute Reports. Industry experts and ...